The data previously obtained in prostate cancer allow to suggest the TRPV6 channel as a tumor promoter in the prostate, being expressed de novo it significantly contributes to PCa cells survival as proliferation and apoptosis resistance, promotes the formation of bone metastasis, and potentiates tumorigenesis in vivo. The gene discussed is TRPV6; the disease is posterior cortical atrophy.